# A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma

> **NCT07436221** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Akeso** · enrollment: 160 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AK139
- **DRUG:** AK139
- **DRUG:** AK139
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07436221
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-28
- **Primary completion:** 2026-12-27
- **Final completion:** 2027-02-26
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07436221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07436221, "A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07436221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*